Alan Frazer

  • 9228 Citations
  • 51 h-Index
1967 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alan Frazer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Antidepressive Agents Medicine & Life Sciences
Lithium Medicine & Life Sciences
Desipramine Medicine & Life Sciences
Serotonin Medicine & Life Sciences
Brain Medicine & Life Sciences
Erythrocytes Medicine & Life Sciences
Cyclic AMP Medicine & Life Sciences
Receptors, Adrenergic, beta Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1975 2018

Research Output 1967 2019

Editorial for Treatment-Resistant Depression (TRD)

Kasper, S. & Frazer, A., Feb 1 2019, In : The international journal of neuropsychopharmacology. 22, 2, p. 83-84 2 p.

Research output: Contribution to journalArticle

Open Access
Treatment-Resistant Depressive Disorder
10 Citations (Scopus)
L 655,708
Ketamine
Antidepressive Agents
Pharmacology
Hippocampus
34 Citations (Scopus)

Vagal Nerve Stimulation for Treatment-Resistant Depression

Carreno, F. R. & Frazer, A., Jul 1 2017, In : Neurotherapeutics. 14, 3, p. 716-727 12 p.

Research output: Contribution to journalReview article

Treatment-Resistant Depressive Disorder
Vagus Nerve Stimulation
Antidepressive Agents
Major Depressive Disorder
Brain
1 Citation (Scopus)

A Neuroscience-based Nomenclature (NbN) for psychotropic agents

Frazer, A. & Blier, P., Aug 1 2016, In : International Journal of Neuropsychopharmacology. 19, 8, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Neurosciences
Terminology

A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents

Frazer, A. & Blier, P., Aug 1 2016, In : The international journal of neuropsychopharmacology. 19, 8

Research output: Contribution to journalEditorial

Psychotropic Drugs
Neurosciences
Terminology